Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Monneret G, Venet F, Pachot A, Lepape A.

Mol Med. 2008 Jan-Feb;14(1-2):64-78. Review.

2.

Innovative therapeutic strategies for restoring lymphocyte functions in septic patients.

Turrel F, Guignant C, Venet F, Lepape A, Monneret G.

Inflamm Allergy Drug Targets. 2008 Sep;7(3):181-6. Review.

PMID:
18782025
3.

[Reversing ICU-acquired immunosuppression: an innovative biomarker-guided therapeutic strategy for decreasing sepsis mortality and nosocomial infection rate].

Monneret G, Lepape A, Venet F.

Pathol Biol (Paris). 2011 Dec;59(6):329-33. doi: 10.1016/j.patbio.2011.02.001. Review. French.

PMID:
21981928
4.

ICU-acquired immunosuppression and the risk for secondary fungal infections.

Monneret G, Venet F, Kullberg BJ, Netea MG.

Med Mycol. 2011 Apr;49 Suppl 1:S17-23. doi: 10.3109/13693786.2010.509744. Review.

PMID:
20718607
5.

Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis.

van der Poll T, Meijers JC.

J Innate Immun. 2010;2(5):379-80. doi: 10.1159/000318190. No abstract available.

6.

Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.

Monneret G, Venet F.

Cytometry B Clin Cytom. 2016 Jul;90(4):376-86. doi: 10.1002/cyto.b.21270. Review.

PMID:
26130241
7.

Flow cytometry developments and perspectives in clinical studies: examples in ICU patients.

Venet F, Guignant C, Monneret G.

Methods Mol Biol. 2011;761:261-75. doi: 10.1007/978-1-61779-182-6_18.

PMID:
21755455
8.

[Pathophysiological basis of surgery-linked sepsis].

Vollmar B.

Chirurg. 2011 Mar;82(3):199-207. doi: 10.1007/s00104-010-2010-7. Review. German.

PMID:
21249327
9.

[The importance of cytokines in the posttraumatic inflammatory reaction].

Hildebrand F, Pape HC, Krettek C.

Unfallchirurg. 2005 Oct;108(10):793-4, 796-803. Review. German.

PMID:
16175346
10.

Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.

Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Chéron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F.

Crit Care. 2011;15(2):R99. doi: 10.1186/cc10112.

11.

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Hotchkiss RS, Monneret G, Payen D.

Nat Rev Immunol. 2013 Dec;13(12):862-74. doi: 10.1038/nri3552. Review.

12.

Sepsis syndromes: understanding the role of innate and acquired immunity.

Oberholzer A, Oberholzer C, Moldawer LL.

Shock. 2001 Aug;16(2):83-96. Review.

PMID:
11508871
13.

Surgical sepsis: dysregulation of immune function and therapeutic implications.

Boontham P, Chandran P, Rowlands B, Eremin O.

Surgeon. 2003 Aug;1(4):187-206. Review.

PMID:
15570763
14.

Volume therapy and innate immune response during systemic inflammation or sepsis.

Dorresteijn MJ, van der Hoeven HG, Pickkers P.

Crit Care Med. 2008 Mar;36(3):1028; author reply 1028-9. doi: 10.1097/CCM.0B013E318162B885. No abstract available.

PMID:
18431319
15.

The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

Ward NS, Casserly B, Ayala A.

Clin Chest Med. 2008 Dec;29(4):617-25, viii. doi: 10.1016/j.ccm.2008.06.010. Review.

16.

B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.

Shubin NJ, Monaghan SF, Heffernan DS, Chung CS, Ayala A.

Crit Care. 2013 Nov 29;17(6):R276. doi: 10.1186/cc13131.

17.

The role of natural killer cells in sepsis.

Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Bléry M, Papazian L, Vivier E.

J Biomed Biotechnol. 2011;2011:986491. doi: 10.1155/2011/986491. Review.

18.
19.

[Physiopathology of severe sepsis].

Caille V, Bossi P, Grimaldi D, Vieillard-Baro A.

Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. Review. French.

PMID:
15029017
20.

[Dendritic cells in sepsis: an approach to post-infectious immunosuppression].

Sirgo G, Claramonte R, Chánovas M, Esteban F, Forcadell I, Luna J, Masdeu G, Ramón Vázquez J, Artigas A.

Med Intensiva. 2010 Nov;34(8):559-66. doi: 10.1016/j.medin.2009.11.005. Review. Spanish.

Supplemental Content

Support Center